Navigation Links
Cantel Medical Corp. Names Andrew Krakauer as CEO and Announces Other Corporate Appointments

LITTLE FALLS, N.J., March 20 /PRNewswire-FirstCall/ -- CANTEL MEDICAL CORP. (NYSE: CMN) announced the promotion of Andrew A. Krakauer, President of the Company, to President and Chief Executive Officer. Mr. Krakauer will also become a member of the Board of Directors. Since joining Cantel in September 2004, Mr. Krakauer served as Executive Vice President and COO, and since April 2008 as President.

The Board concurrently appointed Seth R. Segel, Senior Vice President - Strategy and Corporate Development, to the position of Executive Vice President and Craig A. Sheldon, Senior Vice President - CFO, to the position of Senior Vice President - CFO and Treasurer. In addition, Board member George Fotiades was named Vice Chairman, replacing Alan Hirschfield, who retired from such position on March 18th but remains an active Board member. Mr. Fotiades, who joined the Board in May 2008, will also become a member of the Office of the Chairman, joining Charles M. Diker, Chairman of the Board, along with Messrs. Krakauer and Segel. The new appointments became effective on March 18, 2009.

"Andy is precisely the right leader for Cantel," stated Diker. "Since his appointment to President, Andy has provided decisive leadership and strategic direction. Moreover, the Company's performance has been exceptional since Andy took the helm."

Krakauer said, "I am honored by the Board's confidence in me. I look forward to the continued implementation of our strategic plans for continued growth and global expansion in infection prevention and control markets. I am also very privileged to be working with Cantel's phenomenal group of executives and our entire team of loyal and hardworking employees."

About Cantel Medical Corp.

Cantel Medical Corp. is a leading provider of infection prevention and control products in the healthcare market. Our products include specialized medical device reprocessing systems for renal dialysis and endoscopy, dialysate concentrates and other dialysis supplies, disposable infection control products primarily for the dental industry, water purification equipment, sterilants, disinfectants and cleaners, hollow fiber membrane filtration and separation products for medical and non-medical applications, and specialty packaging for infectious and biological specimens. We also provide technical maintenance for our products and offer compliance training services for the transport of infectious and biological specimens.

For further information, visit the Cantel website at

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks and uncertainties, including, without limitation, the risks detailed in Cantel's filings and reports with the Securities and Exchange Commission. Such forward-looking statements are only predictions, and actual events or results may differ materially from those projected or anticipated.

SOURCE Cantel Medical Corp.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Cantel Medical Corp. and National Safety Council Launch Joint Initiative to Prepare Businesses and Individuals for Flu Pandemic
2. Cantel Medical to Relocate Dutch Manufacturing Operations to the United States to Achieve Operating Savings
3. Cantel Medical Corp. to Present at the Oppenheimer & Co. 19th Annual Healthcare Conference
4. Cantel Medical Corp. to Hold Conference Call to Discuss Results for Its First Quarter Ended October 31, 2008
5. Cantel Medical Reports 72% Increase in Net Income on Record Sales - EPS of $0.20 vs. $0.12 for Quarter Ended October 31, 2008
6. Cantel Medical Corp. to Present at the 11th Annual Needham Growth Stock Conference
7. Cantel Medical Corp.s Medivators Group Gains FDA 510(k) Approval For Its Advantage(TM) Plus Endoscope Reprocessing System
8. Cantel Medical Corp. to Hold Conference Call to Discuss Results for Its Second Quarter Ended January 31, 2009
9. Cantel Medical Reports 75% Increase in Net Income - EPS of $0.23 vs. $0.13 for Quarter Ended January 31, 2009
10. Cantel Medical Corp. to Present at the 13th Annual Sidoti & Company Emerging Growth Institutional Investor Forum
11. MSU engineering team designs innovative medical device
Post Your Comments:
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand ... project," said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s ... within Final Cut Pro X . Simply select a ProHand generator and drag ...
(Date:6/25/2016)... Oklahoma City, Oklahoma (PRWEB) , ... June 25, ... ... to helping both athletes and non-athletes recover from injury. Recently, he has implemented ... for the Oklahoma City area —Johnson is one of the first doctors to ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her ... would lash out at his family verbally and physically. , “When something upset him, he ... he would use it. He would throw rocks at my other children and say he ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda ... orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including ... accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced the addition of ... report to their offering. ... kidney failure, it replaces the function of kidneys by removing ... thus the treatment helps to keep the patient body,s electrolytes ... Increasing number of ESRD patients & substantial healthcare expenditure ...
(Date:6/23/2016)... 2016 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing ... With this clearance, Roche is the first IVD company ... for sepsis risk assessment and management. PCT ... PCT levels in blood can aid clinicians in assessing ...
(Date:6/23/2016)... 23, 2016 Bracket , a leading clinical ... generation clinical outcomes platform, Bracket eCOA (SM) 6.0, at ... 26 – 30, 2016 in Philadelphia , ... Outcome Assessment product of its kind to fully integrate with ... Bracket eCOA 6.0 is a flexible platform for electronic clinical ...
Breaking Medicine Technology: